NEJM review (Hunter & Inouye, 2026): a genome sequenced once could serve for life.
• 6.1% of 1.8M patients in one US system had a genetic test on file
• ~99% of US veterans carry ≥1 actionable drug-response variant
• genotype-guided prescribing: 30% fewer adverse reactions (RCT)
#MedSky #Genomics
NEJM review (Hunter & Inouye, 2026): a genome sequenced once could serve for life. • 6.1% of 1.8M patients in one US system had a genetic test on file • ~99% of US veterans carry ≥1 actionable drug-response variant • genotype-guided prescribing: 30% fewer adverse reactions (RCT) #MedSky #Genomics
0 views
Published on 17/11/2026 10:27
0:22
NEJM review (Hunter & Inouye, 2026): a genome sequenced once could serve for life.
• 6.1% of 1.8M patients in one US system had a genetic test on file
• ~99% of US veterans carry ≥1 actionable drug-response variant
• genotype-guided prescribing: 30% fewer adverse reactions (RCT)
#MedSky #Genomics
1 comment
?
Animated summary of the key numbers (on-screen text in Bulgarian). Full review: doi.org/10.1056/NEJMra2413201